Bd announces emergency use authorization, ce mark for combination molecular diagnostic to detect sars-cov-2, influenza a+b in single test

Franklin lakes, n.j., feb. 12, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that the u.s. food and drug administration (fda) has granted emergency use authorization (eua) for a new molecular diagnostic...
BDX Ratings Summary
BDX Quant Ranking